PharmaBoardroom

Eli Lilly and Innovent take China Partnership Global

The partnership between global pharma giant Eli Lilly and Chinese biotech Innovent Biologics, first initiated in March 2015, continues to bear…

Ketil Widerberg – General Manager, Oslo Cancer Cluster,…

Ketil Widerberg of the Oslo Cancer Cluster highlights how Norway’s excellence in electronic health records can help the country stake out a position…

Kerry Blanchard – CEO, Everest Medicines, China

Dr Kerry Blanchard explains why he took on the challenge of becoming CEO of Chinese biotech Everest Medicines and how Everest’s internationalist…

Ivan Cheung – Chairman, Eisai Inc.; President, Neurology…

Ivan Cheung, head of Japanese firm Eisai’s US operations, highlights the significance of a potential 2021 US FDA approval for Alzheimer’s Disease…

Anne Kjersti Fahlvik – Executive Director, Industries,…

Anne Kjersti Fahlvik of the Research Council of Norway highlights the health sector’s increasing importance to the Nordic nation, the country’s…

French Pharma News Roundup August 2020

A roundup of some of the latest from French pharma, including Sanofi’s bumper Prinicipia deal, how Unither’s new Chinese acquisition catapults it…

Top 10 Pharma Companies in Norway

The top 10 pharma companies in Norway ranked by 2019 turnover according to IQVIA data. The Norwegian market is dominated by multinationals, with…

Opinion: The Paradigm Shift Needed for Effective Alzheimer’s…

Holmusk’s Nawal Roy outlines why a cure for Alzheimer’s Disease is the “Holy Grail” of medicine today, the reasons for so many biotech…

Biotech Spotlight: Alphamab Oncology, China

Founded in 2009 by CEO Dr XU Ting, Alphamab started its journey as a protein engineering company with the ultimate dream of becoming, as many Chinese…

J&J’s Momenta Deal A Further Sign of Big Pharma’s Rare…

In the wake of Sanofi’s USD 3.7 billion tie-up for US biotech Principia, J&J has moved to bolster its autoimmune portfolio with the acquisition…

Lundbeck US Head on COVID-19’s Dramatic Mental Health Impact

PharmaBoardroom recently spoke to CNS-focused Danish biopharma company Lundbeck’s EVP and Head of North America Peter Anastasiou, who highlighted…

China’s 3rd Drug Procurement Round: A Bloodbath for…

Since the Chinese government unrolled an unprecedented volume-based procurement initiative for essential drugs used in the public hospital system in…

Tagged with